Nivolumab induces long-term remission in a patient with fusariosis
| Errataetall: |
ErratumIn: Eur J Cancer. 2023 Mar;181:208-209. - PMID 36639261 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:173 |
|---|---|
| Enthalten in: |
European journal of cancer (Oxford, England : 1990) - 173(2022) vom: 15. Sept., Seite 91-94 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Khatamzas, Elham [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 31.08.2022 Date Revised 13.01.2023 published: Print-Electronic ErratumIn: Eur J Cancer. 2023 Mar;181:208-209. - PMID 36639261 Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.ejca.2022.06.035 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM343831058 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM343831058 | ||
| 003 | DE-627 | ||
| 005 | 20231226021351.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ejca.2022.06.035 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1146.xml |
| 035 | |a (DE-627)NLM343831058 | ||
| 035 | |a (NLM)35863109 | ||
| 035 | |a (PII)S0959-8049(22)00386-0 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Khatamzas, Elham |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Nivolumab induces long-term remission in a patient with fusariosis |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 31.08.2022 | ||
| 500 | |a Date Revised 13.01.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a ErratumIn: Eur J Cancer. 2023 Mar;181:208-209. - PMID 36639261 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 7 | |a Nivolumab |2 NLM | |
| 650 | 7 | |a 31YO63LBSN |2 NLM | |
| 700 | 1 | |a Mellinghoff, Sibylle C |e verfasserin |4 aut | |
| 700 | 1 | |a Thelen, Martin |e verfasserin |4 aut | |
| 700 | 1 | |a Schlößer, Hans A |e verfasserin |4 aut | |
| 700 | 1 | |a Kunz, Wolfgang G |e verfasserin |4 aut | |
| 700 | 1 | |a Buerkle, Carolin |e verfasserin |4 aut | |
| 700 | 1 | |a Dichtl, Karl |e verfasserin |4 aut | |
| 700 | 1 | |a Ormanns, Steffen |e verfasserin |4 aut | |
| 700 | 1 | |a von Bergwelt-Baildon, Michael |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European journal of cancer (Oxford, England : 1990) |d 1991 |g 173(2022) vom: 15. Sept., Seite 91-94 |w (DE-627)NLM012602779 |x 1879-0852 |7 nnns |
| 773 | 1 | 8 | |g volume:173 |g year:2022 |g day:15 |g month:09 |g pages:91-94 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ejca.2022.06.035 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 173 |j 2022 |b 15 |c 09 |h 91-94 | ||